Nitric Oxide to Treat Pulmonary Embolism

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Pulmonary Embolism
Interventions
DRUG

Inhaled Nitric Oxide

Nitric Oxide + oxygen

DRUG

Sham

Nitrogen + Oxygen

Trial Locations (4)

36216

University of Mississippi, Jackson

46202

Eskenazi Hospital, Indianapolis

Indiana University Hospital, Indianapolis

Methodist Hospital, Indianapolis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

collaborator

University of Mississippi Medical Center

OTHER

collaborator

University of Texas, Southwestern Medical Center at Dallas

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Indiana University School of Medicine

OTHER

NCT01939301 - Nitric Oxide to Treat Pulmonary Embolism | Biotech Hunter | Biotech Hunter